The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Novel evidence‐based systemic lupus erythematosus responder index
Open accessAbstract
Objective: To describe a new systemic lupus erythematosus (SLE) responder index (SRI) based on a belimumab phase II SLE trial and demonstrate its potential utility in SLE clinical trials. Methods: Data from a randomized, double‐blind, placebo‐controlled study in 449 patients of 3 doses of belimumab (1, 4, 10 mg/kg) or placebo plus standard of care therapy (SOC) over a 56‐week period were analyzed. The Safety of Estrogens in Lupus Erythematosus: National Assessment (SELENA) version of the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) and British Isles Lupus Assessment Group (BILAG) SLE disease activity instruments, the Short Form 36 health survey, and biomarker analyses were used to create a novel SRI. Response to treatment in a subset of 321 serologically active SLE patients (antinuclear antibodies ≥1:80 and/or anti–double‐stranded DNA antibodies ≥30 IU/ml) at baseline was retrospectively evaluated using the SRI. Results: SRI response is defined as 1) a ≥4‐point reduction in SELENA–SLEDAI score, 2) no new BILAG A or no more than 1 new BILAG B domain score, and 3) no deterioration from baseline in the physician's global assessment by ≥0.3 points. In serologically active patients, the addition of belimumab to SOC resulted in a response in 46% of patients at week 52 compared with 29% of the placebo patients (P = 0.006). SRI responses were independent of baseline autoantibody subtype. Conclusion: This evidence‐based evaluation of a large randomized, placebo‐controlled trial in SLE resulted in the ability to define a robust responder index based on improvement in disease activity without worsening the overall condition or the development of significant disease activity in new organ systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
Self-citation(2016) · Diagnostic Imaging: Brain · doi:10.1016/b978-0-323-37754-6.50094-4 · Cited by 3,990
Development of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L. M., Lightfoot, R., Paulus, H., Strand, V., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380602 · Cited by 2,829
Self-citationOverview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project
Ware, J. E., & Gandek, B. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00081-x · Cited by 2,605
Gladman, D., Ginzler, E., Goldsmith, C., Fortin, P., Liang, M., Sanchez‐Guerrero, J., Urowitz, M., Bacon, P., Bombardieri, S., Hanly, J., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390303 · Cited by 2,582
Self-citationRahman, A., & Isenberg, D. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmra071297 · Cited by 1,632
Merrill, J. T., Neuwelt, C. M., Wallace, D. J., Shanahan, J. C., Latinis, K. M., Oates, J. C., Utset, T. O., Gordon, C., Isenberg, D. A., Hsieh, H., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27233 · Cited by 1,409
Self-citationCombined Oral Contraceptives in Women with Systemic Lupus Erythematosus
Petri, M., Kim, M. Y., Kalunian, K. C., Grossman, J., Hahn, B. H., Sammaritano, L. R., Lockshin, M., Merrill, J. T., Belmont, H. M., Askanase, A. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051135 · Cited by 1,166
Self-citationRahman, M. U. (2008) · Essentials of Physical Medicine and Rehabilitation · doi:10.1016/b978-1-4160-4007-1.50153-x · Cited by 1,019
Buyon, J. P., Petri, M. A., Kim, M. Y., Kalunian, K. C., Grossman, J., Hahn, B. H., Merrill, J. T., Sammaritano, L., Lockshin, M., Alarcón, G. S., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_1-200506210-00004 · Cited by 661
Self-citationManson, J. J., & Rahman, A. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-6 · Cited by 605
Wallace, D. J., Stohl, W., Furie, R. A., Lisse, J. R., McKay, J. D., Merrill, J. T., Petri, M. A., Ginzler, E. M., Chatham, W. W., McCune, W. J., et al. (2009) · Arthritis Care & Research · doi:10.1002/art.24699 · Cited by 585
Self-citation(1993) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068841 · Cited by 567
(1993) · PubMed · Cited by 469
Petri, M., Stohl, W., Chatham, W., McCune, W. J., Chevrier, M., Ryel, J., Recta, V., Zhong, J., & Freimuth, W. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23678 · Cited by 428
Self-citationKalunian, K. C., Davis, J. C., Merrill, J. T., Totoritis, M. C., Wofsy, D., & for the IDEC‐131 Lupus Study Group (2002) · Arthritis & Rheumatism · doi:10.1002/art.10681 · Cited by 336
Self-citationGriffiths, B., Mosca, M., & Gordon, C. (2005) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2005.03.010 · Cited by 328
Rahman, P., Gladman, D. D., Urowitz, M. B., Hallett, D., & Tam, L. S. (2001) · Lupus · doi:10.1191/096120301670679959 · Cited by 288
Classification and definition of major flares in SLE clinical trials
Petri, M., Buyon, J., & Kim, M. (1999) · Lupus · doi:10.1191/096120399680411281 · Cited by 282
Self-citationGuidelines for referral and management of systemic lupus erythematosus in adults
(1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199909)42:9<1785::aid-anr1>3.0.co;2-# · Cited by 269
ONG, L. M., HOOI, L. S., LIM, T. O., GOH, B. L., AHMAD, G., GHAZALLI, R., TEO, S. M., WONG, H. S., TAN, S. Y., SHAARIAH, W., et al. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00444.x · Cited by 252
Cambridge, G., Isenberg, D. A., Edwards, J. C. W., Leandro, M. J., Migone, T.-S., Teodorescu, M., & Stohl, W. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.079418 · Cited by 193
Self-citationOutcome measures to be used in clinical trials in systemic lupus erythematosus.
Strand, V., Gladman, D. D., Isenberg, D. A., Petri, M., Smolen, J. S., & Tugwell, P. (1999) · PubMed · Cited by 179
Self-citationMoroni, G., Doria, A., Mosca, M., Alberighi, O. D. C., Ferraccioli, G., Todesco, S., Manno, C., Altieri, P., Ferrara, R., Greco, S., et al. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02271205 · Cited by 175
Accurately describing changes in disease activity in Systemic Lupus Erythematosus.
Gladman, D., Urowitz, M. B., Kagal, A., & Hallett, D. C. (2000) · PubMed · Cited by 164
Gladman, D., Goldsmith, C. H., Urowitz, M. B., et al. (1992) · PubMed · Cited by 152
Stoll, T. M. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh238 · Cited by 150
Cardiel, M. H., Tumlin, J. A., Furie, R. A., Wallace, D. J., Joh, T., & Linnik, M. D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23673 · Cited by 147
Self-citationWard, M. M., Marx, A. S., & Barry, N. N. (2000) · PubMed · Cited by 146
Petri, M., Mease, P. J., Merrill, J. T., Lahita, R. G., Iannini, M. J., Yocum, D. E., Ginzler, E. M., Katz, R. S., Gluck, O. S., Genovese, M. C., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20427 · Cited by 144
Self-citationDefinition and treatment of lupus flares measured by the BILAG index
Gordon, C. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keg382 · Cited by 141
(2004) · Arthritis & Rheumatism · doi:10.1002/art.20628 · Cited by 138
Cook, R. J., Gladman, D. D., Pericak, D., & Urowitz, M. B. (2000) · PubMed · Cited by 131
Health-related Quality of Life in Patients with Systemic Lupus Erythematosus: An Update
Thumboo, J., & Strand, V. (2007) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v36n2p115 · Cited by 121
Self-citationYee, C., Farewell, V. T., Isenberg, D. A., Rahman, A., Teh, L., Griffiths, B., Bruce, I. N., Ahmad, Y. A., Prabu, A., Akil, M., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23130 · Cited by 116
The BILAG-2004 index is sensitive to change for assessment of SLE disease activity
Yee, C., Farewell, V. T., Isenberg, D. A., Griffiths, B., Teh, L., Bruce, I. N., Ahmad, Y. A., Rahman, A., Prabu, A., Akil, M., et al. (2009) · Lara D. Veeken · doi:10.1093/rheumatology/kep064 · Cited by 115
Smolen, J. S., Strand, V., Cardiel, M. H., Edworthy, S. M., Furst, D. E., Gladman, D. D., Gordon, C., Isenberg, D. A., Klippel, J. H., Petri, M., et al. (1999) · PubMed · Cited by 111
Self-citationFrom BILAG to BLIPS—disease activity assessment in lupus past, present and future
Isenberg, D. A., & Gordon, C. (2000) · Lupus · doi:10.1191/096120300672904669 · Cited by 109
Stoll, T. M., Stucki, G., Malik, J., Pyke, S. D. M., & Isenberg, D. A. (1996) · Annals of the Rheumatic Diseases · doi:10.1136/ard.55.10.756 · Cited by 91
Strand, V., & Crawford, B. (2005) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.5.3.317 · Cited by 81
Self-citationLessons learned from clinical trials in SLE
Strand, V. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2006.08.002 · Cited by 25
Self-citation
Cited by
Navarra, S. V., Guzmán, R. M., Gallacher, A. E., Hall, S., Levy, R. A., Jimenez, R. E., Li, E. K.-M., Thomas, M., Kim, H.-Y., León, M. G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61354-2 · Cited by 2,074
Self-citationFurie, R., Petri, M., Zamani, O., Cervera, R., Wallace, D. J., Tegzová, D., Sanchez-Guerrero, J., Schwarting, A., Merrill, J. T., Chatham, W. W., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30613 · Cited by 1,683
Self-citationKaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, M. B., van Vollenhoven, R., Ruiz-Irastorza, G., & Hughes, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.39 · Cited by 1,391
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
Morand, E. F., Furie, R., Tanaka, Y., Bruce, I. N., Askanase, A. D., Richez, C., Bae, S.-C., Brohawn, P. Z., Pineda, L., Berglind, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1912196 · Cited by 1,379
Self-citationFurie, R., Khamashta, M., Merrill, J. T., Werth, V. P., Kalunian, K., Brohawn, P., Illei, G. G., Drappa, J., Wang, L., Yoo, S., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.39962 · Cited by 882
Self-citation
Metadata
- Authors
- Furie, R. A., Petri, M. A., Wallace, D. J., Ginzler, E. M., Merrill, J. T., Stohl, W., Chatham, W. W., Strand, V., Weinstein, A., Chevrier, M. R., Zhong, Z. J., & Freimuth, W. W.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2009-08-27
- Volume
- 61
- Issue
- 9
- Pages
- 1143-1151
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W2091468965
- Cited by
- 490
- References
- 45
- FWCI
- 21.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.